Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Glycomimetics Inc (GLYC)  
$0.27 0.03 (10.54%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 47,830,000
Market Cap: 12.75(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.298 - $3.49
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   GlycoMimetics is a clinical-stage biotechnology company focused on the discovery and development of glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a main role. Co. is developing uproleselan, a specific E-selectin inhibitor, to be used in combination with chemotherapy to treat patients with acute myeloid leukemia, a hematologic cancer, and potentially other hematologic cancers. Co. is also developing a drug candidate, GMI-1359, that simultaneously targets both E-selectin and a chemokine receptor known as CXCR4. Co. has designed an antagonist of E-selectin, GMI-1687, that could be suitable for subcutaneous administration.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 65,403 2,581,565
Total Buy Value $0 $0 $90,256 $4,837,462
Total People Bought 0 0 1 9
Total Buy Transactions 0 0 2 21
Total Shares Sold 0 0 3,700 4,053,849
Total Sell Value $0 $0 $7,215 $12,677,616
Total People Sold 0 0 1 2
Total Sell Transactions 0 0 1 6
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 116
  Page 5 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Barris Peter J 10% Owner   –       –       •   2015-11-16 4 OE $0.33 $3,117 I/I 9,445 4,491,203     -
   Barrett M James Director   –       •       •   2015-11-16 4 S $6.91 $3,123 I/I (452) 4,490,751     -
   Barrett M James Director   –       •       •   2015-11-16 4 OE $0.33 $3,117 I/I 9,445 4,491,203     -
   Nea Partners 10 L P 10% Owner   –       –       •   2015-11-16 4 S $6.91 $3,123 D/D (452) 4,490,751     -
   Nea Partners 10 L P 10% Owner   –       –       •   2015-11-16 4 OE $0.33 $3,117 D/D 9,445 4,491,203     -
   Hahn Brian M. CFO   •       –      –    2015-02-27 4 OE $1.12 $5,600 D/D 5,000 14,085     -
   King Rachel K. President, CEO   •       •      –    2015-02-24 4 OE $1.12 $56,000 D/D 50,000 167,206     -
   Henos Michael A Director   –       •      –    2014-12-22 4 S $8.44 $89,913 I/I (10,659) 469,454     -
   Henos Michael A Director   –       •      –    2014-12-19 4 S $8.61 $91,277 I/I (10,598) 480,113     -
   Henos Michael A Director   –       •      –    2014-12-17 4 S $8.97 $45,935 I/I (5,121) 490,711     -
   Henos Michael A Director   –       •      –    2014-12-15 4 S $8.98 $14,404 I/I (1,604) 495,832     -
   Henos Michael A Director   –       •      –    2014-12-15 4 OE $0.33 $14,397 I/I 43,628 497,436     -
   Goldberg Mark Alan Director   –       •      –    2014-07-08 3 IO $0.00 $0 D/D 0 1,100     -
   King Rachel K. President, CEO   •       •      –    2014-06-18 4 OE $1.12 $112,000 D/D 100,000 108,706     -
   Henos Michael A Director   –       •      –    2014-06-13 4 B $6.21 $31,050 D/D 5,000 12,562 2.39     -
   Henos Michael A Director   –       •      –    2014-06-12 4 B $6.54 $39,240 D/D 6,000 7,562 2.39     -

  116 Records found
  1  2  3  4  5    
  Page 5 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed